ADMA Biologics Inc vs Lithium Americas Corp — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Lithium Americas Corp trades at $3.27 (market cap $1.18B). The key difference: ADMA Biologics Inc is the larger of the two by market cap. Which is the better fit depends on your goals.
| ADMA | LAC | |
|---|---|---|
Market Cap | $2.22B | $1.18B |
Sector | Health | Basic Materials |
52-Week High | $20.38 | $10.05 |
52-Week Low | $7.60 | $2.71 |
Enterprise Value | $2.29B | $1.29B |
Trailing returns across standard periods
Latest headlines on both assets
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →Lithium Americas is a resource company focused on developing the Thacker Pass project in Nevada, the largest known lithium resource in the US. It aims to become a major supplier for the electric vehicle battery market.
Read more on LAC →